**PURPOSE:** Surgical-site infection is a major concern in prosthetic-based breast reconstruction. Some infections are mild, resolving with outpatient antibiotic treatment, and others are more severe, requiring hospital readmission for treatment with IV antibiotics. Explant of the tissue expander or implant is one of the most feared complications. Thirty-day postoperative readmission rates are a common quality metric, but little is known about readmission rates for later infection after prosthetic-based breast reconstruction. We used the Nationwide Readmissions Database (NRD) to determine the rates and predictors of early and late hospital readmissions associated with infection and explantation after prosthetic-based breast reconstruction.

**METHODS:** Using the 2013--2014 NRD, we identified breast cancer patients undergoing prosthetic-based breast reconstruction (implants and tissue expanders) who had an infectious readmission within 90 days following their procedure using ICD-9 diagnosis and procedure codes. We used univariate and multivariate logistic regression models to identify patient demographics, comorbidities, and hospital predictors of infectious readmission and explantation within the early (0--30 day) and late (31--90 day) postoperative time-periods.

**EXPERIENCE:** In a weighted sample of the NRD, we identified 18,339 patients who underwent prosthetic-based breast reconstruction from 2013--2014. We identified patients who had an infectious readmission within 0--90 days of their index procedure.

**RESULTS:** The overall infectious readmission rate for this group was 4.1% (n=759 patients). Only 49.3% of such readmissions occurred within the initial 30 days after surgery, and 50.7% occurred 31 - 90 days after surgery. Of those admitted for infection, 39.5% (n=300 patients) had their implant or tissue expander explanted. Most explantations occurred during late readmissions (55.1%). Median annual household income \<\$40,000 (OR 1.44, p=0.030), diabetes (OR 1.52, p=0.040), obesity (OR 1.70, p=0.004), and length of stay during the index procedure (OR 1.07, p=0.045) were independent predictors of overall infectious readmission. Diabetes (OR 1.75, p=0.038) and hypertension (OR 1.74, p=0.008) were independent predictors of early 0--30 day infectious readmissions. Medicaid status (OR 1.72, p=0.037), median annual household income \<\$40,000 (OR 1.67, p=0.029), obesity (OR 1.95, p=0.005), and length of hospital stay during the index procedure (OR 1.09, p=0.025) were independent predictors of late 31--90 day infectious readmissions. No statistically significant predictors for implant or tissue expander explantation were identified.

**CONCLUSION:** Late hospital readmissions for infections in the setting of prosthetic-based breast reconstruction are common. Traditional thirty-day readmission rates may not be an adequate quality metric for breast reconstruction given the number of late postoperative readmissions, many of which lead to explantation. Early and late infectious readmissions have different predictors, and further work finding interventions that target these predictors may decrease the number of readmissions, saving cost while improving quality for both the patient and the healthcare system.
